In March 2025, the company declared new programs for any direct-to-consumer providing of its Wegovy weight loss drug. The company founded a brand new pharmacy, named NovoCare, which would charge consumers $499 every month for usage of the drug, less than half the price of the drug through other pharmaceutical distribution networks.[fifty three]Rese